购物车
- 全部删除
- 您的购物车当前为空
Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of lipid storage diseases and Fabry disease.
Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of lipid storage diseases and Fabry disease.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,100 | 5日内发货 | |
25 mg | ¥ 7,840 | 6-8周 | |
50 mg | ¥ 10,400 | 6-8周 | |
100 mg | ¥ 16,100 | 6-8周 |
产品描述 | Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of lipid storage diseases and Fabry disease. |
别名 | NBDGJ |
分子量 | 219.28 |
分子式 | C10H21NO4 |
CAS No. | 141206-42-0 |
密度 | 1.234 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容